O1-4-1 - Effects of Dose Modifications on Safety and Efficacy of Dacomitinib for EGFR+ NSCLC in ARCHER 1050 Japanese Subset

Autor: Kato, Terufumi, Nishio, Makoto, Niho, Seiji, Yamamoto, Noboru, Takahashi, Toshiaki, Nogami, Naoyuki, Kaneda, Hiroyasu, Fujita, Yuka, Wilner, Keith, Yoshida, Mizuki, Isozaki, Mitsuhiro, Wada, Shinsuke, Tsuji, Fumito, Nakagawa, Kazuhiko
Zdroj: In Annals of Oncology October 2019 30 Supplement 6:vi83-vi83
Databáze: ScienceDirect